Treating cancer by blocking cell signals.
Adjei
Alex A
AA
Mayo Clinic College of Medicine, Rochester, MN, USA.
Hidalgo
Manuel
M
D000818:Animals; D001549:Benzamides / Q000627:therapeutic use*; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000037:antagonists & inhibitors*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D020935:MAP Kinase Signaling System / Q000187:drug effects*; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology
C120227:2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide; D001549:Benzamides; D004791:Enzyme Inhibitors; D017871:Calcium-Calmodulin-Dependent Protein Kinases